Assembly Biosciences medical chief sells 2,564 shares
The Chief Medical Officer's sales were mandated to fund tax withholding under an administrative rule, rather than discretionary transactions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Assembly Biosciences, Inc.'s Chief Medical Officer Anuj Gaggar reported a performance-based restricted stock unit award covering 13,705 shares; its performance-based vesting condition was achieved October 30, 2026. On November 2, 2026, he sold 2,564 shares at a weighted-average price of $19.6077 per share and 29 shares at $20.3480 per share. Both sales funded tax withholding through mandated sell-to-cover transactions and were not discretionary.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F2, F3 | 2,564 | $19.6077 | $50K |
| Sale | Common Stock F2, F4 | 29 | $20.348 | $590.09 |
| Grant/Award | Common Stock F1 | 13,705 | $0.00 | $0.00 |
Footnotes (4)
- F1. Represents shares of common stock issuable under a performance-based restricted stock unit award dated June 16, 2025. On October 30, 2026, the performance-based vesting condition was achieved. These shares of common stock vest in two equal installments, assuming continuous service on each vesting date, as follows: October 30, 2026 and October 30, 2027.
- F2. The sales reported on this Form 4 represent shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales are mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the reporting person.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.28 to $20.27, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.30 to $20.37, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
Key Figures
Key Terms
performance-based restricted stock unit award financial
sell-to-cover transaction financial
weighted average price financial
tax withholding obligations financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When do Anuj Gaggar's performance-based ASMB RSUs vest?
What price ranges applied to Anuj Gaggar's ASMB sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.